1/40
Vocabulary flashcards covering delirium types, causes, nursing care, neurocognitive domains, Alzheimer's disease pathophysiology and manifestations, Lewy body and prion diseases, vascular neurocognitive disorders, TBI classification, and dementia assessment tools and pharmacotherapy.
Delirium
An acute disturbance in attention and awareness accompanied by additional cognitive changes, characterized by a sudden onset developing over hours or days, which fluctuates and is potentially reversible when the underlying cause is treated.
Major Neurocognitive Disorder
A cognitive disorder that generally develops gradually over months or years and involves progressive cognitive deterioration.
Hyperactive Delirium
A subtype of delirium characterized by agitation, restlessness, increased motor activity, irritability, and difficulty remaining calm or being redirected.
Hypoactive Delirium
A subtype of delirium manifested by apathy, reduced responsiveness, decreased motor activity, and an empty or vacant gaze, which is often overlooked because the client appears quiet rather than disruptive.
Mixed Delirium
A subtype of delirium that alternates between hyperactive and hypoactive manifestations.
Unclassified Delirium
A category of delirium that does not fit into the hyperactive, hypoactive, or mixed classifications.
Delirium Tremens (DTs)
A severe, potentially fatal complication of alcohol withdrawal marked by severe confusion, agitation, tremors, sweating, tachycardia, nausea, vomiting, hallucinations, altered consciousness, and seizures.
Complex Attention
A neurocognitive domain encompassing sustained attention, divided attention, selective attention, and processing speed.
Executive Function
A neurocognitive domain that includes planning, decision-making, working memory, responding to feedback, mental flexibility, and overriding habitual responses.
Language (Neurocognitive Domain)
A neurocognitive domain involving expressive language, receptive language, grammar, syntax, naming objects, and understanding words.
Perceptual-Motor Function
A neurocognitive domain that includes visual perception, visuoconstructional ability, praxis, and gnosis.
Social Cognition
A neurocognitive domain defined as the ability to recognize emotions, understand the thoughts and feelings of others, and respond appropriately in social situations.
Beta-Amyloid Plaques
Accumulations of beta-amyloid peptides that form plaques outside and between neurons, interfering with normal neuronal functioning in Alzheimer's disease.
Neurofibrillary Tangles
Abnormal accumulations of tau protein inside neurons that clump together and contribute to neuronal dysfunction and cell death in Alzheimer's disease.
Hippocampus
A brain structure essential for short-term memory that experiences progressive neuronal loss early in Alzheimer's disease, explaining initial difficulty with retaining recent information.
Sundowning
A phenomenon characterized by increased confusion or behavioral symptoms occurring later in the day or evening.
Perseveration
The persistent repetition of the same words, thoughts, or behaviors.
Confabulation
Filling gaps in memory with inaccurate or fabricated information without the conscious intention to deceive.
Aphasia
Impaired language ability affecting expressive communication or comprehension.
Apraxia
Difficulty performing learned, purposeful movements despite intact motor function.
Agnosia
Difficulty recognizing familiar objects, people, or sensory information.
Hyperorality
A behavioral manifestation characterized by compulsively putting objects into the mouth.
Hypermetamorphosis
A behavioral manifestation involving the compulsive urge to touch or handle objects.
Functional Assessment Staging Tool (FAST)
An assessment instrument used to evaluate functional decline and staging progression in dementia, ranging from no functional change through severe dependence.
Lewy Body Dementia
A neurocognitive disorder associated with alpha-synuclein aggregates (Lewy bodies), characterized by fluctuating cognition, recurrent visual hallucinations, spontaneous parkinsonian signs, and severe neuroleptic sensitivity.
Creutzfeldt-Jakob Disease
A prion disease associated with rapidly progressive cognitive decline, ataxia, myoclonus, and exposures such as contaminated meat, infected animal tissue, transplanted corneas, or human growth hormone.
Myoclonus
Sudden, involuntary muscle jerks.
Ataxia
Impaired muscle coordination.
Vascular Neurocognitive Disorder
A neurocognitive disorder caused by vascular damage and reduced cerebral blood flow, typically displaying a variable course with declines and plateaus, affecting attention, processing speed, and frontal executive function.
Mild Traumatic Brain Injury (Mild TBI)
A traumatic brain injury characterized by loss of consciousness of 30minutes or less, post-traumatic amnesia of 1day or less, alteration of consciousness or confusion of 1day or less, a GCS score of 13–15, and normal CT or MRI imaging.
Complicated Mild Traumatic Brain Injury
A traumatic brain injury defined by mild clinical severity criteria and a GCS score of 13–15, but accompanied by an abnormal CT or MRI scan.
Moderate Traumatic Brain Injury
A traumatic brain injury characterized by loss of consciousness from 30minutes to 24hours, post-traumatic amnesia from 1 to 7days, alteration of consciousness from 1 to 7days, a GCS score of 9–12, and normal or abnormal neuroimaging.
Severe Traumatic Brain Injury
A traumatic brain injury defined by loss of consciousness of 24hours or more, post-traumatic amnesia of 7days or more, alteration of consciousness of 7days or more, a GCS score of 3–8, and normal or abnormal neuroimaging.
Confusion Assessment Method (CAM)
An assessment tool identified by ATI used specifically to evaluate and detect delirium.
NEECHAM Confusion Scale
A clinical rating scale identified by ATI utilized as an assessment tool for delirium.
Functional Dementia Scale
An assessment instrument identified by ATI that evaluates self-care ability, memory, mood, and safety.
Brief Interview for Mental Status (BIMS)
A cognitive screening tool identified by ATI that is specifically utilized in long-term care settings.
Mini-Mental State Examination (MMSE)
A standardized assessment tool identified by ATI used for general cognitive screening.
Blessed Dementia Scale
A cognitive assessment scale identified by ATI that collects functional and behavioral data from a secondary source, such as a family member.
Cholinesterase Inhibitors
A medication class (including donepezil, rivastigmine, and galantamine) that inhibits the breakdown of acetylcholine to increase its availability at synapses; adverse effects include nausea, vomiting, diarrhea, bradycardia, and syncope.
Memantine
A medication approved for moderate-to-severe Alzheimer's disease that can be combined with cholinesterase inhibitors; common adverse effects include dizziness, headache, and constipation.